Less anti-malarials ( 51.2 % vs 100.0 % , p < 0.001 ) and antibiotics ( 29.7 % vs 48.7 % , p < 0.001 ) , were prescribed in the test-treat group on completion of study , more test-treat package patients were clinically well ( 99.2 % vs 80.7 % , p < 0.001 ) and febrile ( 0.8 % vs 10.1 % , p = 0.001 ) and less were admitted for inpatient care ( 0.0 % vs 8.4 % p = 0.001 ) compared to the routine care group .